Virtual Lobby Day and Lobby Week is fast approaching, but this is not your average Lobby Day. In fact, we may not see its like again. The stars have finally been aligning for us. Long COVID is a hot subject – it just got over a billion dollars in funding....
A retrospective study suggests that low dose Abilify is safe and may be helpful in reducing fatigue and post-exertional malaise and improving cognition and sleep in chronic fatigue syndrome. A placebo-controlled study is needed to determine how effective low dose Abilify is.
How a person with chronic fatigue syndrome (ME/CFS) improved their health and quality of life by pacing using heart rate and heart rate variability monitoring
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.